PerkinElmer has earned a CE mark for its DELFIA Xpress sFlt-1 pre-eclampsia diagnostic kit.
The blood test is designed for pregnant women in the second and third trimester. It measures the ratio of soluble Fms-like tyrosine-kinase-1 (sFlt-1). Abnormally high levels of the sFlt-1 protein have been linked to pre-eclampsia.
The company previously launched a test that measures placental growth factor, DELFIA Xpress PIGF 1-2-3, optimized for screening in the first trimester.